Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

Medicine Matters oncology

David F. Heigener is head of the department of pulmonology at the Helios Klinik Schleswig, Germany. His main interest is medical treatment of lung cancer. He participated in numerous trials in this field with approximately 100 publications and book contributions. He is also a member of the palliative care task force in the German Respiratory Society (Deutsche Gesellschaft für Pneumologie).



Professor Heigener is Member of IASLC, ESMO, German Respiratory Society (DGP), German Cancer Society (DKG) and the German Society for Palliative Medicine (DGP). He is on the Editorial Board of Atemwegs- und Lungenkrankheiten and Reviewer for The Lancet, The Lancet Oncology, Lung Cancer, Respiratory Medicine, Annals of Oncology, British Medical Journal, Journal of Clinical Oncology and Journal of Thoracic Oncology.